Medical Cannabis

Medical Cannabis Value Chain.

Photo by Shutterstock

Medical Cannabis Value Chain.

Country
Sector
Most major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Health Care
Sub Sector
Most major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Biotechnology and Pharmaceuticals
Indicative Return
Describes the rate of growth an investment is expected to generate within the IOA. The indicative return is identified for the IOA by establishing its Internal Rate of Return (IRR), Return of Investment (ROI) or Gross Profit Margin (GPM).
5% - 10% (in IRR)
Investment Timeframe
Describes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.
Medium Term (5–10 years)
Market Size
Describes the value of potential addressable market of the IOA. The market size is identified for the IOA by establishing the value in USD, identifying the Compound Annual Growth Rate (CAGR) or providing a numeric unit critical to the IOA.
USD 100 million - USD 1 billion
Average Ticket Size (USD)
Describes the USD amount for a typical investment required in the IOA.
USD 500,000 - USD 1 million
Direct Impact
Describes the primary SDG(s) the IOA addresses.
Good health and well-being (SDG 3) Decent Work and Economic Growth (SDG 8)
Indirect Impact
Describes the secondary SDG(s) the IOA addresses.
Responsible Consumption and Production (SDG 12) Climate Action (SDG 13) Life on Land (SDG 15)

Business Model Description

Growing cannabis for medicinal purposes and processing its flower harvest to obtain oil to be used in the treatment of illnesses. Thus achieving agro-industrial growth, technological investment and the development of new sources of employment.

How is this information gathered?

Investment opportunities with potential to contribute to sustainable development are based on country-level SDG Investor Maps.

Disclaimer

UNDP, the Private Finance for the SDGs, and their affiliates (collectively “UNDP”) do not seek or solicit investment for programmes, projects, or opportunities described on this site (collectively “Programmes”) or any other Programmes, and nothing on this page should constitute a solicitation for investment. The actors listed on this site are not partners of UNDP, and their inclusion should not be construed as an endorsement or recommendation by UNDP for any relationship or investment.

The descriptions on this page are provided for informational purposes only. Only companies and enterprises that appear under the case study tab have been validated and vetted through UNDP programmes such as the Growth Stage Impact Ventures (GSIV), Business Call to Action (BCtA), or through other UN agencies. Even then, under no circumstances should their appearance on this website be construed as an endorsement for any relationship or investment. UNDP assumes no liability for investment losses directly or indirectly resulting from recommendations made, implied, or inferred by its research. Likewise, UNDP assumes no claim to investment gains directly or indirectly resulting from trading profits, investment management, or advisory fees obtained by following investment recommendations made, implied, or inferred by its research.

Investment involves risk, and all investments should be made with the supervision of a professional investment manager or advisor. The materials on the website are not an offer to sell or a solicitation of an offer to buy any investment, security, or commodity, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction.

Read More

Country & Regions

Explore the country and target locations of the investment opportunity.
Country
Region
  • San Juan Province
  • Sarmiento City
Learn more

Sector Classification

Situate the investment opportunity within sustainability focused sector, subsector and industry classifications.
Sector

Health Care

Development needs
Argentina invests more than 9% of its GDP in health, one of the highest levels among Latin American and Caribbean countries. However, the country achieves lower health outcomes than would be expected for this level of investment and its level of per capita income (1). There is a need to ensure better access to health for all inhabitants.

Policy Priority
According to the Strategic Plan of the Province of San Juan and the challenges and goals defined therein, the most important policy priorities have focused on adapting the workforce to the expected changes in the health system and achieving an equitable distribution in accordance with the health needs of the population (2).

Gender inequalities and marginalisation
Rural and poor people do not have equal access to medical services and medication.

Investment opportunities
To deepen investment in research and development, it is essential to take a step forward to discover original products, with Argentine patents, the other major challenge has to do with improving the accessibility of these products to the entire population.

Bottlenecks
Although the entire population living in Argentina is formally covered by some health sub-system (public, social security or private), timely, continuous, comprehensive, safe and quality access is far from universal and shows significant disparities according to location and sub-system (1).

Sub Sector

Biotechnology and Pharmaceuticals

Development needs
Argentina's pharmaceutical industry is characterised by a high import component. There is a need to strengthen the domestic pharmaceutical industry to guarantee supply and thus improve access to medicine in general.

Political Priority
The San Juan Government, by means of Law 1951- A, has supported the creation of Ca. Me. San Juan, an organisation that promotes cultivation, research and new financial instruments for the development of agro-industrial projects linked to medical cannabis (3).

Gender inequalities and marginalisation
Rural and poor people do not have equal access to medical services and medication.

Investment opportunities
There is a significant opportunity for growth in the cultivation and industrialisation of cannabis for medicinal purposes, as well as for the inputs used in the production process, as many of them have to be imported or purchased outside the Province of San Juan.

Bottlenecks
The area is still developing in our country, so the main obstacles are associated with the lack of current regulation that does not yet allow the commercialisation of locally grown and industrialised cannabis oil for medicinal purposes.

Industry

Biotechnology and Pharmaceuticals

Pipeline Opportunity

Discover the investment opportunity and its corresponding business model.
Investment Opportunity Area

Medical Cannabis Value Chain.

Business Model

Growing cannabis for medicinal purposes and processing its flower harvest to obtain oil to be used in the treatment of illnesses. Thus achieving agro-industrial growth, technological investment and the development of new sources of employment.

Business Case

Learn about the investment opportunity’s business metrics and market risks.

Market Size and Environment

Market Size (USD)
Describes the value in USD of a potential addressable market of the IOA.

USD 100 million - USD 1 billion

In Argentina there are an estimated number of 5,274,654 potential medical cannabis users (5), who would have to pay an average of USD 80 per bottle of oil to cover one month of treatment.

The cannabis market in Argentina could reach USD 450 million (5).

The Bank of Toronto estimates a global market for medical cannabis of USD 194 billion by 2025. Other more modest projections such as BDS Analytics foresee a USD 47 billion market in North America by 2027.

Indicative Return

IRR
Describes an expected annual rate of growth of the IOA investment.

5% - 10%

Based on estimates from interviewed companies that are starting their projects in the province.

Investment Timeframe

Timeframe
Describes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.

Medium Term (5–10 years)

The cultivation method used allows for 3 to 4 harvests per year. This makes it possible to diversify the risks of the initial investment over several harvests.

Ticket Size

Average Ticket Size (USD)
Describes the USD amount for a typical investment required in the IOA.

USD 500,000 - USD 1 million

Market Risks & Scale Obstacles

Business - Supply Chain Constraints

High electricity consumption is required to provide artificial light for the plants. When the projects are in full production, it will not be possible to meet the demand with the power plants in the area.

Market - Highly Regulated

There are multiple international and national legislations and control bodies because in the country cannabis is only allowed for medicinal or industrial use, but not for recreational use. In the province, only companies authorised by Canme can cultivate on their premises for this purpose.

Capital - CapEx Intensive

Large amounts of capital are required to finance the initial investment as all projects have to be set up from scratch, as this is a previously undeveloped area.

Impact Case

Read about impact metrics and social and environmental risks of the investment opportunity.

Sustainable Development Need

In Argentina, 48.2% of people who use cannabis for medicinal purposes have to buy it. Either importing it at high costs or buying it in unregulated markets with dubious qualities (6).

The Province of San Juan has an economically active population of 41.8%, of which only 30.3% are fully employed (7).

Gender & Marginalisation

People with insufficient income find it difficult to afford medical cannabis treatments due to the high costs of acquiring them.

In San Juan Province less than half of the jobs are held by women (no official statistics).

Expected Development Outcome

Increasing the areas of cultivation of cannabis for medicinal purposes, thus ensuring better access and quality conditions for people who use it for medical indications.

Increasing full and productive employment.

Gender & Marginalisation

Increase local production of cannabis oil for medicinal use, thus improving the quality of life and health of users with insufficient income, as they will be able to access better conditions for purchasing medication (in terms of price and quality).

Increase the number of women in employment.

Primary SDGs addressed

Good health and well-being (SDG 3)
3 - Good Health and Well-Being

3.8.1 Coverage of essential health services

Current Value

64% of the population is covered by social or private health insurance. Thirty-six per cent of the population receives care in public health services. Despite this, access to health care is far from universal and shows significant disparities according to location and sub-system.

Target Value

That 100% of health system users can access the health system under more favourable conditions and at lower costs.

Decent Work and Economic Growth (SDG 8)
8 - Decent Work and Economic Growth

8.5.2 Unemployment rate, by sex, age and persons with disabilities

Current Value

The province's unemployment rate is low (4%) in relation to other provinces, but full employment and consideration of more women employed in relation to men must be achieved (8).

Target Value

It is expected that 50% of the jobs will be filled by women.

Secondary SDGs addressed

Responsible Consumption and Production (SDG 12)
12 - Responsible Consumption and Production
Climate Action (SDG 13)
13 - Climate Action
Life on Land (SDG 15)
15 - Life on Land

Directly impacted stakeholders

People

People who could have better access to medicine and thus gain a better quality of life.

Corporates

Companies that have begun investing in the only cultivation site licensed by Canme (a state-owned company dedicated to guaranteeing equal access to cannabis oil).

Planet

The environment could be improved by increasing the cultivation and production of cannabis needed for general health improvement.

Public sector

Through its company Canme, which prudently manages public resources in order to be a reference in the cultivation, processing and production of preparations from medicinal cannabis.

Indirectly impacted stakeholders

People

Community in general that will benefit from the increase in jobs.

Corporates

Companies that are part of the productive chain that will benefit from the growth of this industry.

Public sector

Which will benefit from increased tax revenues from industrial growth.

Outcome Risks

Changes in the regulations enabling the production of cannabis/hemp in the province, taking into account that the authorisation of companies and establishments must be approved in advance.

Difficulties in obtaining skilled labour in the area of cultivation (Ca.Me. premises, the only place authorised by provincial regulations to develop cannabis and hemp cultivation).

Lack of resources and/or inputs or limited access to them on the local or international market.

Impact Risks

Evidence risk: Lack of research that provides quality data, lack of statistics and measurement of the sector.

Participation risk: Lack of knowledge in the medical field of the medicinal benefits of cannabis for certain pathologies.

Risk of unexpected impact: Adverse weather conditions complicate crops and put the industry at risk.

External Risk: There may be international competitors who are more knowledgeable and take better advantage of the opportunities offered by the market, with a lower price for consumers.

Impact Classification

C—Contribute to Solutions

What

Improve access to medical coverage, allowing users more favourable conditions, at lower prices and guaranteed quality, thus improving their health and quality of life.

Who

Individuals who suffer from a certain health condition and fit the profile of a potential cannabis user.

Risk

Impossibilities of access to medical cannabis, thus impairing people's health and quality of life.

Enabling Environment

Explore policy, regulatory and financial factors relevant for the investment opportunity.

Policy Environment

The Government of the Province of San Juan has included cannabis cultivation in its strategic plan, with programmes and projects that promote its industrial development.

Financial Environment

From the Ministry of Production and Economic Development of the Province, incentives are granted for the installation of new companies that take into account sustainable development models, under the modality of Non-Refundable Contributions and credits with very competitive rates.

Tax incentives: Gross Income Tax reductions and exemptions for agricultural activities. In addition to tax incentive programmes such as those managed by the San Juan Investment Agency with tax bonds to encourage sustainable investment projects.

Regulatory Environment

Provincial regulation: Law 1951 that creates the State Company called Ca. Me, in order to guarantee equal access to medical cannabis oil to patients who need it and to promote the training of health professionals in the medical use of cannabis.

National Regulation: Law 27.350 that endorses medical and scientific research into the medicinal use of the cannabis plant. It proposes the creation of a National Register of patients undergoing treatment with cannabis under the responsibility of the Ministry of Health.

National Regulations Law 27669 establishes the regulatory framework for the production and commercialisation chain of the cannabis plant and its derivatives for both medicinal and industrial use.

International Regulations: There are three bodies that decide on the UN international conventions on narcotic drugs: Commission on Narcotic Drugs CND, National Narcotics Control Board INCB, World Health Organisation WHO.

Marketplace Participants

Discover examples of public and private stakeholders active in this investment opportunity that were identified through secondary research and consultations.

Government

Government sector with the following organisations and companies: Canme, INTA, SENASA, INASE, ANMAT, National Ministry of Security, National Ministry of Health.

Private Sector

Business chambers and companies such as Mediplant, Cann 4.0 and Green Health, are already installed in the enabled venue with their investment projects underway.

Target Locations

See what country regions are most suitable for the investment opportunity. All references to Kosovo shall be understood to be in the context of the Security Council Resolution 1244 (1999)
country static map
rural

San Juan Province

The only place in the province authorised to cultivate cannabis/hemp is the property owned by the company Ca.Me, in the locality of Campogrande del Acequión, Department of Sarmiento. It has the necessary climatic and security conditions for this crop.
rural

Sarmiento City

References

See what sources were used to establish the investment opportunity’s data and find resources that could be consulted to explore more.
    • (1) Document: Argentina - Programme for the integration of the Argentinean health system. conditional credit line for investment projects - IDB
    • (2) Strategic Plan of the Province of San Juan - 2019
    • (3) www.canmesanjuan.com.ar
    • (4) https://www.greenhealth.ar
    • (5) According to analysis year 2021 based on number of cases according to prevalence - "Cannabis and Argentina" state of play, industry and trade projection - Cámara Argentina de Cannabis.
    • (6) First National Survey of people who use cannabis in Argentina 2022- Centro de Estudios de la cultura cannábica - Universidad de Quilmes - THC Magazine
    • (7) INDEC Technical Report, Vol. 6, No. 237. Third Quarter 2022
    • (8) Source INDEC report 1st quarter 2022.